Assessing the sensibility and utility of a short-form version of the HIV Disability Questionnaire in clinical practice settings in Canada, Ireland and the USA: a mixed methods study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
29 09 2022
Historique:
entrez: 29 9 2022
pubmed: 30 9 2022
medline: 4 10 2022
Statut: epublish

Résumé

The Short-Form HIV Disability Questionnaire (SF-HDQ) was developed to measure the presence, severity and episodic nature of health challenges across six domains. Our aim was to assess the sensibility, utility and implementation of the SF-HDQ in clinical practice. Mixed methods study design involving semistructured interviews and questionnaire administration. We recruited adults living with HIV and HIV clinicians in Canada, Ireland and the USA. We electronically administered the SF-HDQ followed by a Sensibility Questionnaire (face and content validity, ease of usage, format) and conducted semistructured interviews to explore the utility and implementation of the SF-HDQ in clinical practice. The threshold for sensibility was a median score of Median sensibility scores were The SF-HDQ possesses sensibility and utility for use in clinical settings with adults living with HIV and HIV clinicians in three countries.

Identifiants

pubmed: 36175103
pii: bmjopen-2022-062008
doi: 10.1136/bmjopen-2022-062008
pmc: PMC10098270
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e062008

Subventions

Organisme : NIA NIH HHS
ID : R21 AG062380
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054366
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Natl Cancer Inst. 2011 May 4;103(9):753-62
pubmed: 21483021
AIDS. 2014 Aug 24;28(13):1939-43
pubmed: 24992000
Health Qual Life Outcomes. 2021 Jan 6;19(1):6
pubmed: 33407538
AIDS. 2006 Nov 14;20(17):2165-74
pubmed: 17086056
Curr HIV/AIDS Rep. 2014 Sep;11(3):279-90
pubmed: 24966138
Phys Ther. 1998 Oct;78(10):1073-82
pubmed: 9781701
Med Care. 1992 May;30(5 Suppl):MS50-6
pubmed: 1583941
Health Qual Life Outcomes. 2017 May 30;15(1):115
pubmed: 28558805
J Int AIDS Soc. 2009 Nov 09;12:5
pubmed: 19900284
Phys Ther. 2020 Oct 30;100(11):1906-1909
pubmed: 32737967
Lancet. 2021 Jul 31;398(10298):382-383
pubmed: 34332676
AIDS Care. 2016 Nov;28(11):1428-33
pubmed: 27237187
Prog Community Health Partnersh. 2014 Winter;8(4):549-59
pubmed: 25727988
JAMA. 1995 Jan 4;273(1):59-65
pubmed: 7996652
Lancet HIV. 2017 Aug;4(8):e349-e356
pubmed: 28501495
Clin Infect Dis. 2011 Dec;53(11):1130-9
pubmed: 21998280
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
J Assoc Nurses AIDS Care. 2011 Jan-Feb;22(1):17-25
pubmed: 20471864
AIDS Behav. 2018 Mar;22(3):752-764
pubmed: 27990582
Health Qual Life Outcomes. 2008 Oct 04;6:76
pubmed: 18834538
PLoS One. 2022 May 12;17(5):e0267271
pubmed: 35551320
Qual Life Res. 2016 Feb;25(2):293-302
pubmed: 26245710
Clin Infect Dis. 2011 Dec;53(11):1120-6
pubmed: 21998278
Health Qual Life Outcomes. 2015 Aug 12;13:124
pubmed: 26263898
Qual Health Res. 2017 Mar;27(4):591-608
pubmed: 27670770
Neurology. 2010 Dec 7;75(23):2087-96
pubmed: 21135382
CMAJ. 2008 Jul 29;179(3):245-52
pubmed: 18663204
Disabil Rehabil. 2013 Apr;35(7):566-77
pubmed: 22816434
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
AIDS Care. 2009 Mar;21(3):322-8
pubmed: 19280409
AIDS Care. 2012;24(8):963-71
pubmed: 22519889
AIDS Res Ther. 2020 May 19;17(1):21
pubmed: 32429973
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
Disabil Rehabil. 2015;37(13):1193-201
pubmed: 25116628
Soc Sci Med. 2021 Oct;286:114326
pubmed: 34425522
PLoS One. 2019 Jul 10;14(7):e0213222
pubmed: 31291243
Neurology. 2004 Sep 14;63(5):822-7
pubmed: 15365130
Health Qual Life Outcomes. 2017 Nov 15;15(1):220
pubmed: 29141645
BMC Public Health. 2014 Feb 13;14:161
pubmed: 24524286
BMJ Open. 2014 Sep 01;4(8):e005456
pubmed: 25180054

Auteurs

Kelly K O'Brien (KK)

Department of Physical Therapy, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada kelly.obrien@utoronto.ca.
Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Rehabilitation Sciences Instiute (RSI), University of Toronto, Toronto, Ontario, Canada.

Patricia Solomon (P)

School of Rehabilitation Science, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.

Soo Chan Carusone (SC)

McMaster Collaborative for Health and Aging, School of Nursing, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Casey House, Toronto, Ontario, Canada.

Kristine M Erlandson (KM)

University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Colm Bergin (C)

Department of Genitourinary and Infectious Diseases (GUIDE) Clinic, St James's Hospital, Dublin, Ireland.
School of Medicine, Trinity College Dublin, Dublin, Ireland.

Ahmed M Bayoumi (AM)

Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
MAP Centre, St Michael's Hospital, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Steven E Hanna (SE)

Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

Richard Harding (R)

Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, Cicely Saunders Institute, King's College London, London, UK.

Darren A Brown (DA)

Therapies Department, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.

Jaime H Vera (JH)

Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK.
Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.

Marta Boffito (M)

Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.

Carolann Murray (C)

Casey House, Toronto, Ontario, Canada.

Rachel Aubry (R)

Department of Physical Therapy, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.

Noreen O'Shea (N)

Department of Genitourinary and Infectious Diseases (GUIDE) Clinic, St James's Hospital, Dublin, Ireland.

Natalie St Clair-Sullivan (N)

Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.

Mallory Boyd (M)

University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Marilyn Swinton (M)

Department of Physical Therapy, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.

Brittany Torres (B)

Department of Physical Therapy, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.

Aileen M Davis (AM)

Department of Physical Therapy, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH